Arcutis Clinical Study Site 108 — Meridian, Idaho

Arcutis Clinical Study Site 108 is a clinical research site located in Meridian, Idaho, United States 83646.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Arcutis Clinical Study Site 108 has participated in 1 clinical trials.

Therapeutic areas: Psoriasis.

Sponsors: Arcutis Biotherapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Meridian

Browse all research sites in Idaho · View every site in Meridian

• Idaho State University
• Idaho State University - Meridian
• Saint Luke's Cancer Institute - Meridian
• Idaho Urologic Institute-Meridian
• Advanced Clinical Research
• Solaris Clinical Research
• Research Site
• Saint Luke's Mountain States Tumor Institute - Meridian
• Velocity Clinical Research Boise
• GSK Investigational Site
• Velocity Clinical Research
• Idaho Urologic Institute

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Arcutis Clinical Study Site 108?

Arcutis Clinical Study Site 108 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Arcutis Clinical Study Site 108 conducted?

Arcutis Clinical Study Site 108 has 1 clinical trials on record. Their work covers Psoriasis.

Is Arcutis Clinical Study Site 108 accredited by Crixeo Clinical Trials?

Arcutis Clinical Study Site 108 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Arcutis Clinical Study Site 108?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.